Dlx-2 is implicated in TGF-β-and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation

International Journal of Oncology

Volumn 46, Issue 4, 2015, Pages 1768-1780

  Lee, Su Yeon ^a   Jeon, Hyun Min ^a   Ju, Min Kyung ^a   Jeong, Eui Kyong ^a   Kim, Cho Hee ^a,c   Yoo, Mi Ae ^a   Park, Hye Gyeong ^a   Han, Song Iy ^b   Kang, Ho Sung ^a  

^a Pusan National University   (South Korea)

^b Chosun University   (South Korea)

^c National Forensic Service   (South Korea)

Author keywords

COXVIc; Dlx 2; Epithelial mesenchymal transition; Glycolytic switch; Snail

Indexed keywords

CYTOCHROME C OXIDASE; DLX 2 PROTEIN; PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; WNT3A PROTEIN; DISTAL-LESS HOMEOBOX PROTEINS; HOMEODOMAIN PROTEIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL POLARITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE REPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION SITE; WNT SIGNALING PATHWAY; ANIMAL; BREAST TUMOR; DOG; FEMALE; GENETICS; HCT116 CELL LINE; MCF 7 CELL LINE; MDCK CELL LINE; METABOLISM; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOGS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GLYCOLYSIS; HCT116 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MADIN DARBY CANINE KIDNEY CELLS; MCF-7 CELLS; MITOCHONDRIA; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; WNT SIGNALING PATHWAY;

EID: 84923103896     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2874     Document Type: Article

References (30)

1. DE CRAENE B and BERX G: Regulatory networks defning EMT during Cancer initiation and progression. Nat Rev Cancer 13: 97-110, 2013.
2. NIETO MA: The snail superfamily of zinc-fnger transcription factors. Nat Rev Mol Cell Biol 3: 155-166, 2002.
3. PUISIEUX A, BRABLETZ T and CARAMEL J: Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol 16: 488-494, 2014.
4. THIERY JP and SLEEMAN JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006.
5. ZHENG H and KANG Y: Multilayer control of the EMT master regulators. Oncogene 33: 1755-1763, 2014.
6. LIU YN, LEE WW, WANG CY, CHAO TH, CHEN Y and CHEN JH: Regulatory mechanisms controlling human E-cadherin Gene expression. Oncogene 24: 8277-8290, 2005.
7. POLYAK K and WEINBERG RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem Cell traits. Nat Rev Cancer 9: 265-273, 2009.
8. THIERY JP, ACLOQUE H, HUANG RY and NIETO MA: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
9. LEE SY, JEON HM, JU MK, et al: Wnt/Snail signaling regulates cytochrome c oxidase and glucose metabolism. Cancer Res 72: 3607-3617, 2012.
10. CAIRNS RA, HARRIS IS and MAK TW: Regulation of Cancer Cell metabolism. Nat Rev Cancer 11: 85-95, 2011.
11. DANG CV: Links between metabolism and cancer. Genes Dev 26: 877-890, 2012.
12. HSU PP and SABATINI DM: Cancer Cell metabolism: Warburg and beyond. Cell 134: 703-707, 2008.
13. VANDER HEIDEN MG, CANTLEY LC and THOMPSON CB: Understanding the Warburg effect: The metabolic requirements of Cell proliferation. Science 324: 1029-1033, 2009.
14. WARBURG O: On the origin of Cancer cells. Science 123: 309-314, 1956.
15. ALIROL E and MARTINOU JC: Mitochondria and cancer: Is there a morphological connection? Oncogene 25: 4706-4716, 2006.
16. BRANDON M, BALDI P and WALLACE DC: Mitochondrial mutations in cancer. Oncogene 25: 4647-4662, 2006.
17. KROEMER G: Mitochondria in cancer. Oncogene 25: 4630-4632, 2006.
18. GOGVADZE V, ORRENIUS S and ZHIVOTOVSKY B: Mitochondria in Cancer cells: What is so special about them? Trends Cell Biol 18: 165-173, 2008.
19. MERLO GR, ZEREGA B, PALEARI L, TROMBINO S, MANTERO S and LEVI G: Multiple functions of Dlx genes. Int J Dev Biol 44: 619-626, 2000.
20. PANGANIBAN G and RUBENSTEIN JL: Developmental functions of the Distal-less/Dlx homeobox genes. Development 129: 4371-4386, 2002.
21. LEE SY, JEON HM, KIM CH, et al: Homeobox Gene Dlx-2 is implicated in metabolic stress-induced necrosis. Mol Cancer 10: 113, 2011.
22. TANG P, HUANG H, CHANG J, ZHAO GF, LU ML and WANG Y: Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma. World J Gastroenterol 19: 2697-2703, 2013.
23. YILMAZ M, MAASS D, TIWARI N, et al: Transcription factor Dlx2 protects from TGFbeta-induced cell-cycle arrest and apoptosis. EMBO J 30: 4489-4499, 2011.
24. HUSSAIN SP, HOFSETH LJ and HARRIS CC: Radical causes of cancer. Nat Rev Cancer 3: 276-285, 2003.
25. WEINBERG F and CHANDEL NS: Reactive oxygen species-dependent signaling regulates cancer. Cell Mol Life Sci 66: 3663-3673, 2009.
26. KIM CH, JEON HM, LEE SY, et al: Implication of snail in metabolic stress-induced necrosis. PLoS One 6: E18000, 2011.
27. YOON YS, LEE JH, HWANG SC, CHOI KS and YOON G: TGF beta1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene 24: 1895-1903, 2005.
28. SARIBAN-SOHRABY S, MAGRATH IT and BALABAN RS: Comparison of energy metabolism in human normal and neoplastic (Burkitt's lymphoma) lymphoid cells. Cancer Res 43: 4662-4664, 1983.
29. BATLLE E, SANCHO E, FRANCI C, et al: The transcription factor snail is a repressor of E-cadherin Gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
30. YOOK JI, LI XY, OTA I, et al: A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast Cancer cells. Nat Cell Biol 8: 1398-1406, 2006.